VMGI Stock UPDATES Verde Media Group Inc (VMGI) 0.0056 08/21/2014

New Post Public Reply Private Reply Replies (0) Message Board

Aug 21, 2014 at 3:05 PM

Verde Media Group Inc (VMGI) 0.0056 $VMGI

Verde Media Biotech Division Announces Key Manufacturing Partners for Beautyject Inc. Product Launch
GlobeNewswire - Thu Aug 21, 7:15AM CDT
Verde Media Group Inc. (OTC:VMGI) announces key strategic manufacturing partners for the launch and mass production of the initial product line from its majority-owned subsidiary, Beautyject Inc.

Verde Media Biotech Division Advances on Alternative Proprietary Technology for Scaled Cannabinoid Production
GlobeNewswire - Tue Aug 12, 8:02AM CDT
Verde Media Group Inc. (OTC:VMGI) through its Verde Media Biotechnology Division (VMBD) announces plans for genetically modifying a proprietary strain of yeast to produce cannabis-identical phytocannabinoids, including D9 tetrahydrocannabinol (THC) and cannabidiol (CBD). The VMBD team will use the tool of metabolic engineering that allows transfer of Cannabis genetic pathways in yeast, representing an alternative route to produce cannabinoids, at an affordable and scalable manner.

Verde Media Group Inc. CEO, William Veve, Interviewed Live on ABC Radio's "The Amilya Show" to Introduce BeautyJect Inc.
GlobeNewswire - Wed Jul 23, 7:36AM CDT
Verde Media Group Inc. (OTC:VMGI) is an emerging growth biotechnology company. Through its subsidiary, Beautyject Inc., it will provide needle-free injectable devices with a unique patented technology and design. Verde Media CEO, William Veve introduced the product prior to its official launch in North and South American markets during the months to come. Mr. Veve was interviewed live by host Amilya Antonetti on ABC Talk Radio's "The Amilya Show."

William Veve, CEO of Verde Media Group Inc., Will Be Interviewed Live to Introduce BeautyJect Inc. on ABC Radio -- The Amilya Show
Marketwire - Fri Jul 11, 9:53AM CDT
Verde Media Group Inc. (PINKSHEETS: VMGI), a provider of needle-free injectable devices and an emerging growth Biotechnology company, announces today that Chief Executive Officer (CEO) William Veve will be interviewed live by host Amilya Antonetti on ABC Talk Radio's "The Amilya Show," Saturday, July 12th at 1:30pm ET.

Verde Media Group Inc. to Launch Proprietary Deep Well Fermentation Technology for Omega-3 Production in Asia
GlobeNewswire - Thu Jul 10, 7:15AM CDT
Verde Media Group Inc. (OTC:VMGI), through its Verde Media Biotechnology Division ("VMBD"

is preparing for the next phase of construction for its Pilot and semi-commercial Omega-3 oil production facility in Asia. The company broke ground on the project in May of this year and is currently poised to begin building the most crucial and cost-effective part of the facility.

Verde Media Group Inc. Announces Initial Product Line of Cosmetic Injectables From Beautyject Inc. for North American Launch
GlobeNewswire - Mon Jun 30, 7:15AM CDT
Verde Media Group Inc. (OTC:VMGI) has announced the initial product line from its majority-owned subsidiary, Beautyject Inc. Comprised of a slate of needle-free, over-the-counter cosmetic injectables, this new product line is poised for its North American release by a top-tier sales and marketing firm and comfortably occupies its own niche in the industry.

Verde Media Group Inc. Announces Significant Growth of Advisory Board for Beautyject Inc. as Exclusive Technology Approaches North American Release and Distribution
GlobeNewswire - Thu Jun 26, 7:15AM CDT
Verde Media Group Inc. (OTC:VMGI) has announced that its majority-owned subsidiary, Beautyject Inc. continues to further advance its pool of elite industry professionals on its advisory panel as it prepares its North American product launch. Currently, the company is in advanced discussions with a world-renowned ex-senior executive of one of the largest cosmetics companies in the world to join the Beautyject team.

Verde Media Group Inc. Biotech Division Launches Mobile VMBD-03 Laboratory to Serve the Omega-3 Project in Asia
GlobeNewswire - Wed Jun 25, 2:00PM CDT
Verde Media Group Inc. (OTC:VMGI) through its Verde Media Biotechnology Division ("VMBD"

announces the set-up plans for the launch of the VMBD-03 rapid omega-3 oil profiling laboratory with joint-venture partner Phoenix Energy in Asia.

Verde Media Group Inc. Announces Establishment of R&D Division to Select and Develop Overseas Nursery for High-CBD Cannabis Cultivars
GlobeNewswire - Mon Jun 23, 7:15AM CDT
Verde Media Group Inc. (OTC:VMGI) has announced it is in the process of creating a research and development laboratory set-up to determine the optimal strain of commercial cannabis to produce the highest cannabidiol (CBD) content possible. The laboratory will be able to select and optimize the most efficient cultivars for high CBD production and will be capable of clonal expansion for a much larger facility.

Verde Media Group Inc. Announces Signing of Definitive Agreement with Power Shark Capital for the North American Launch of Beautyject Inc.
PR Newswire - Thu Jun 12, 2:00PM CDT
Verde Media Group Inc. (OTC: VMGI) is pleased to announce that it has signed a definitive agreement, through its subsidiary Beautyject Inc., with an internationally-recognized team from Power Shark Capital (PSC) for the marketing, sale and distribution of its cosmetic products throughout the United States and Canada.

Verde Media Group Inc. Advances New Science For The Medical and Cosmetic Industry
PR Newswire - Wed Apr 02, 7:15AM CDT
Verde Media Group Inc. (OTC: VMGI) Verde Media Group Inc. is pleased to announce that it is has entered into the medical and cosmetics industry through its newly created subsidiary Beautyject Inc. Beautyject is in final negotiations to in-license a unique proprietary needleless technology redefining known delivery methods.

Verde Media Group Inc. Biotech Division Announces Completion of Butazyme Acquisition
PR Newswire - Mon Mar 31, 7:15AM CDT
Verde Media Group Inc. (OTC: VMGI) and its Biotech Division ("VMBD"

announce they have completed the acquisition of the privately held biotechnology company Butazyme LLC. Under the terms of the agreement VMGI through its wholly owned subsidiary VMBD, acquired 51% equity of Butazyme LLC. valued at $5.0 million USD

Huffington Post Commentator Steve Kurlander Featured On The Alan Berman Show POT-CAST Brought To You By Verde Media Group Inc.
PR Newswire - Thu Mar 27, 11:30AM CDT
Verde Media Group Inc. (OTC: VMGI)

Verde Media Group Inc. President, William Veve Interviewed on International Trading Radio Show, TheStockRadio.com
PR Newswire - Thu Mar 27, 8:00AM CDT
Verde Media Group Inc. (OTC: VMGI) President, William Veve will be making an appearance today on TheStockRadio.com. His interview focused primarily on VMGI's current strategies regarding its Agency and Biotech divisions and their substantial moves within the expanding legal marijuana market in the United States.

Verde Media Group Inc. Announces Grow Facility Has Passed Inspections
PR Newswire - Tue Mar 25, 7:15AM CDT
Verde Media Group Inc. (OTC: VMGI) announces scheduled inspections have taken place on time to close the P&S agreement by its Diversified Agency Division (VDAD) in Denver, Colorado. The property at 795 S. Jason Street is a 6,000 square foot industrial space that will house Verde's first partnered, OPC growing facility operated by master grower, Ryan McGowan.

Bud From Vapecritic.com Featured On The Alan Berman Show POT-CAST Brought To You By Verde Media Group Inc.
PR Newswire - Fri Mar 21, 8:56AM CDT
Verde Media Group Inc. (OTC: VMGI)

Dr. Lester Grinspoon Featured On The Alan Berman Show POT-CAST Brought To You By Verde Media Group Inc.
PR Newswire - Thu Mar 20, 10:16AM CDT
Verde Media Group Inc. (OTC: VMGI)

Verde Media Group, Inc. Announces Detailed Biotechnology Initiative
PR Newswire - Thu Mar 20, 7:15AM CDT
Verde Media Group Inc. (OTC: VMGI) has formed the Verde Media Biotechnology Division ("VMBD"

. The VMBD division undertakes the business of developing and producing high value bio-products from renewable biomass. The focus and criterion is to develop proprietary microbial technologies with low risk scale-up methods that employ low cost feedstock.

Verde Media Group Inc. Biotech Division to Establish Novel Microbial Technology to Produce Highly Specific and Purified Marijuana Oils
PR Newswire - Tue Mar 18, 7:15AM CDT
Verde Media Group Inc. (OTC:VMGI) through its Verde Media Biotechnology Division ("VMBD"

announces the addition of cutting edge microbial technology program to produce cannabis-based phytocannabinoids products, including delta-9 tetrahydrocannabinol (THC) and cannabidiol (CBD). The VMBD team will use the tool of metabolic engineering to transfer cannabis genetic pathways in microbes representing an alternative route to produce cannabinoids at an affordable and scalable manner.

Allen F. St. Pierre of NORML Featured On The Alan Berman Show Brought To You By Verde Media Group Inc.
PR Newswire - Fri Mar 14, 9:30AM CDT
Verde Media Group Inc. (OTC: VMGI) -- Allen F. St. Pierre Executive Director of NORML and The NORML Foundation will be on todays Marijuana Pot-Cast hosted by Alan Berman. Mr. St. Pierre has appeared on hundreds of nationally televised news programs (ABC, CBS, NBC, CNN, C-Span, Fox, PBS,) and on over 1,000 radio shows representing NORML's point of views on the topic of marijuana.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

CVS Study: GLP-1 Drugs Effective But Costly

By Hannah Lewis Updated Nov 15, 2026 Category News Views 105

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

IDEAYA's IDE101: A New Front in Cancer Battle

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Uber Data Breach: Class Action Investigation Begins

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Employment Law Suit Hits ABC: Alleged Wage Violations

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

WHO and RCSI Bahrain Join Forces on Health Initiatives

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Berry Street Integrates AI with What Matters: Human Touch

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Novo's CagriSema Trials Show Promising Weight Loss

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Investors Gear Up for Lennar Class Action Lawsuit

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...